
Cablivi (caplacizumab-yhdp) is the first approved treatment for adults with acquired thrombotic thrombocytopenic purpura (aTTP).

Cablivi (caplacizumab-yhdp) is the first approved treatment for adults with acquired thrombotic thrombocytopenic purpura (aTTP).

Flu vaccination reduced influenza-related hospitalizations by 38% among patients with COPD.

The updated software will begin being implemented this month for use with the Prometra Pump System.

A new study confirmed that HIV infection significantly increases the risk of death for patients with hepatocellular carcinoma.

Heart patients discharged from the hospital with an opioid prescription were less likely to participate in planned follow-up care than those without prescribed opioids.

A new cohort analysis shows patients switching or adding on the antipsychotic drug are not at a worse risk of suicide or other adverse events.

Parents hoping to spare their children from colds and the flu follow scientific recommendations in high numbers, but they are also susceptible to unscientific “folklore.”

The USPSTF continues to recommend universal prophylactic treatment with erythromycin ointment for all newborns.

In the past 5 years, the administration has continually improved on the previous year's rate. More of the same should be anticipated in 2019.

Some of the changes come in response to growing concern about antimicrobial resistant strains of gonorrhea.

Investigators say they’ve developed a more accurate model for tracking and predicting the spread of influenza.

A new study found the biggest burden of benzodiazepine-related visits have come from primary care physicians, and that efforts to limit sedative prescription may have to start there.

New research based on more than a quarter-million patient records shows vaccinating patients against the flu while hospitalized is safe.

For 2 years after C difficile infection, patients under 65 years were at greater risk for gastrointestinal diagnoses compared to uninfected patients.

The device is being developed to prevent muscle atrophy and reduce days of ventilator support.

Investigators hope their findings will alleviate clinicians’ concerns about choosing between fidaxomicin and oral vancomycin for treatment.

Tobacco farm region physicians face the challenges of culture, law, and education in improving cessation.

This expands the indication of the flu vaccine’s .5 mL dose to this younger age group.

The TactiCath Contact Force Ablation Catheter is used for cardiac ablation procedures.

Older age was associated with a lower likelihood of entering the ICU, but increased risk of death for hospitalized patients with influenza.

University of Washington investigators found great disparities in AEMT-driven death rates among states and age groups.

Coronary artery disease remains the top killer of Americans—these tools may help identify people who are still at risk.

Currently in phase 1 testing, ACX-362E is being developed as a narrow spectrum antibiotic for the treatment of Clostridium difficile infection.

Success with metronidazole was more likely in patients 65 years and under but was about the same as with vancomycin in those patients.

The Amplatzer Piccolo Occluder is implanted via catheter to repair patent ductus arteriosus in newborns weighing as little as 2 pounds.